Alzamend Neuro has partnered with Massachusetts General Hospital to conduct a pioneering Phase II clinical trial of its AL001 treatment for PTSD, led by Dr. Ovidiu Andronesi.
Tag: ALZN Stock
Bitcoin(BTC)$63,294.726.16%
Ethereum(ETH)$2,458.126.78%
Tether USDt(USDT)$1.000.01%
BNB(BNB)$567.215.01%
Solana(SOL)$143.4911.84%
USDC(USDC)$1.000.00%
XRP(XRP)$0.593.98%
Dogecoin(DOGE)$0.1061685.57%
Toncoin(TON)$5.775.15%
TRON(TRX)$0.1514641.15%